Evaluation of safety and efficacy of telmisartan-amlodipine combination in treating hypertension.


The objective of this open, non-comparative, prospective postmarketing surveillance (PMS) study was to identify, validate and quantify the safety and efficacy associated with the use of fixed dose combination (FDC) of telmisartan 40 mg + amlodipine 5 mg (T40+A5) in hypertensive patients with or without concomitant diabetes. The data was collected from 72… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.